in one building, and CO2 exceeded the recommended limit value of 1000 ppm in 26% of the dwellings, showing insufficient outdoor air supply. Bronchial hyperresponsiveness was related to indoor concentration of limonene, the most prevalent terpene. Variability in PEF was related to two other terpenes; a-pinen and 6-karen. Conclusion-Our results suggest that indoor VOCs and formaldehyde may cause asthma-like symptoms. There is a need to increase the outdoor air supply in many dwellings, and wall to wall carpeting and dampness in the building should be avoided. Improved indoor environment can also be achieved by selecting building materials, building construction, and indoor activities on the principle that the emission of volatile organic compounds should be as low as reasonably achievable, to minimize symptoms related to asthma due to indoor air pollution. (Occup Environ Med 1995;52:388-395) 
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The study population of our study consisted of two groups of subjects further selected from the subsample. The first group was all subjects (n = 74) who had reported at least one of the following symptoms in the screening questionnaire: attacks of asthma during the past 12 months, nocturnal breathlessness in the past 12 months, or current use of asthma medication. Also, 80 subjects who gave negative answers to all these three questions were randomly selected, without matching.
These 154 subjects were contacted by post and by phone, and were offered air monitoring of their dwelling. These field measurements were performed from October 1991 to April 1992, as were the clinical investigations.
The study was blinded, to the extent that information from the exposure measurements was not linked to the medical information, until the data collection was completed. The protocol of the study was approved by the Ethics Committee of the Medical Faculty of Uppsala University.
ASSESSMENT OF EXPOSURE
Room temperature, air humidity, VOCs, respirable dust, and carbon dioxide concentration (CO2) were measured in the living room and the bedroom in the houses of all participants. In the bedroom, additional measurements of formaldehyde, and guanine from house dust mites were performed. Measurements in the living room were performed in the centre of the room, 1 0 m above the floor. Bedroom measurements were performed beside the pillow of the bed, at the same height above the floor as the pillow. The bedroom door was closed, and no subject stayed in the bedroom during the VOC, CO2, respirable dust, and formaldehyde measurements.
Room temperature and air humidity were recorded with an Assman psychrometer. Concentrations of respirable dust were measured by a direct reading instrument based on light scattering (Sibata P-5H2, Sibata Scientific Technology, Japan 23 All questions were translated to Swedish and then back to English, to minimise translation bias. The recall period for airway symptoms was 12 months. The questionnaire also contained questions on the dwelling, social situation, education, and environmental exposures. Symptoms related to asthma were defined as reported in the interview to have had in the past 12 months: (a) wheezing or whistling in the chest; or (b) at least one daytime attack of shortness of breath during exercise or at rest; (c) at least one wakeful night because of breathlessness or tightness in the chest.
In addition, information on age, sex, and smoking habits was collected from the screening and interview questionnaire. Current smoker was defined as a subject who reported current smoking in the interview, or had stopped smoking less than a year ago.
Assessment of clinical signs Atopy-Skin prick tests were carried out in a standardised way, by means of lancets coated with allergen (Phazets, Pharmacia Diagnostics, Uppsala, Sweden). The following allergens were tested: Dermatophagoides pteronyssinus (house dust mite), cat, dog, birch, Cladosporium, olive, ragweed, mugwort, timothy, and Alternaria. Histamine was used as a positive control. As proposed by Dreborn, atopy was defined as a prick test reaction to at least one of the allergens, with a mean diameter of 3 mm or greater.24 A nega tive control was used, and its mean diameter was subtracted from that of the allergens. From each volunteer, 35 ml of venous blood was collected, just before the methacholine provocation test. The same investigation sequence was applied to all participants. Blood eosinophil counts were analysed on a Hemalog 2R (Technicon Chemicals Company, Tournai, Belgium) in blood (5 ml) supplemented with ethylene diamine tetraacetic acid (EDTA, 034 mol/l). The concentration of eosinophilic cationic protein (S-ECP) was measured by means of a double antibody radioimmunoassay (Pharmacia Diagnostics AB, Uppsala, Sweden).29 The coefficients of variation within and between assays are less than 11 %, and the detection limit is less than 2 ,ug/l. The 20 ml blood sample used to measure S-ECP was allowed to coagulate for 60 minutes at room temperature after sampling. After that it was centrifuged for 10 minutes, the serum was poured into a new tube and then centrifuged again for 10 minutes. The serum was collected thereafter and kept frozen at -70°C until analysed. Also, serum from another 10 ml of blood was collected, and analysed for total serum immunoglobulin E (S-IgE) by the Pharmacia CAP system (Pharmacia Diagnostics AB, Uppsala, Sweden). STATISTICAL 
METHODS
An unpaired t test was used to study relations between asthmatic symptoms and independent continuous variables that were roughly normally distributed (room temperature, air humidity, and carbon dioxide concentration). The Mann-Whitney U test was applied for the crude analysis of relations between symptoms and other exposures that were not normally distributed (VOCs, respirable dust, and formaldehyde). The x2 test or Fisher's exact test, depending on the number in the cells, was used for analysis of the relation between binary dependent and independent variables, Kendal rank correlation test (Tau-beta) was used when testing correlation between clinical signs and measured environmental exposures. Multivariate statistical analysis was performed by multiple logistic regression with the SPIDA statistical package (the Statistical Laboratory, Macquarie University, Australia).30 Logarithmic values of formaldehyde and VOCs were applied in the model. The collinearity diagnostics described in the SPIDA manual were applied, and adjusted odds ratios (ORs) with a 95% confidence interval (95% CI) were calculated. Adjustments were made for potential confounders: age, sex, and current smoking. To reduce detected collinearity problems, the data on formaldehyde and VOCs were centred by subtracting the mean concentration from each person. In all statistical analyses, two tailed tests and a 5% level of significance was applied.
Results
The total response rate in the initial self administered questionnaire survey was 87%. In the second part, the response rate was 81 % (figure). Of the 154 subjects chosen for this study, 26 (17%) were excluded because of migration. They had either moved to another dwelling during the study period (n = 19), or were working or living outside the municipality of Uppsala during the field study period (n = 7). The non-participants (n = 40) consisted of 14 subjects who did not come to the medical investigation, 12 who could not be contacted at their home address, and 14 refused to participate in the exposure measurements. The remaining 88 subjects (57%) participated in the medical interview, had lived in the same dwelling during the study period, and gave their approval for the measurements in their home. The non-participants did not differ from the participants for age, reported symp (7) years, and the mean (range) duration in the present dwelling was six (0-5-31) years. The mean (SD) FEV, was 106% (13%) of the predicted value, and the mean (range) variability in PEF was 5% (1-18%). Subjects with symptoms related to asthma had a higher prevalence of asthmatic medication, bronchial hyperresponsiveness, and were more often women. In contrast, the proportion of current smokers, and subjects with atopy, were similar among subjects with and without asthmatic symptoms ( The study population and response rates. 6 5 Presence of house dust mites* 21 
5*
Presence of wall to wall carpets 19 17 Visible signs of dampness in the building: 23 
7* Ventilation system
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I Sum of unidentified compounds with a retention time below benzene.
ftSum of all identified and unidentified compounds. In the initial analysis, a significant relation between any type of symptom related to asthma and concentration of total VOCs was found (P < 0-01). The relation between carpeting, CO2, formaldehyde, and total VOCs and asthmatic symptoms was most pronounced for nocturnal dyspnoea (table 3) . Wheezing or whistling in the chest and daytime attacks of shortness of breath showed no significant relations to any measured exposures. Significant relations between nocturnal breathlessness and various subclasses of VOCs were also detected (table 3). The average concentrations of most compounds were similar in bedrooms and the living room, and a large proportion of the VOCs were low boiling VOCs that consisted of unidentified compounds with a boiling point lower than benzene (table 3) . tOdds ratio for an increase of the indoor concentration by 1000 ppm CO2 adjusted for age, sex, current smoking, presence of wall to wall carpets, and presence of house dust mites.
tSum of ethylbenzene, m-xylene, o-xylene, and p-xylene. §Sum of a-pinene, 5-carene, and limonene. ¶Sum of unidentified compounds with a retention time below benzene.
ISum of all identified and unidentified volatile organic compounds.
Some subclasses of VOCs were strongly related to each other and to total VOCs, particularly toluene, C8-aromates (xylene and ethylbenzene), n-alkanes, and low boiling VOCs. In contrast, butanols or terpenes were not significantly related to total VOCs. Significant relations between presence of house dust mites and the concentration of total VOCs, and some subclasses of VOCs, were also found. The total concentration of VOCs was 1050,ug/m' in buildings that had house dust mites, and 350 yug/M3 in buildings without house dust mites (P < 0 05), but no relation was found between total VOCs and signs of microbial growth or dampness in the building. Carbon dioxide, a surrogate measure of the rate of air exchange, was related to total VOCs, but not related to formaldehyde or the presence of house dust mites. Formaldehyde concentration was higher in dwellings with wall to wall carpets (P < 0 05), but no relation was found between carpeting and total VOCs.
To further evaluate the effect of formaldehyde and different VOCs statistical modelling by multiple logistic regression analysis was applied. Those seven classes of VOCs where the concentration in both the bedroom and the living room were significantly related to symptoms in the crude analysis were selected for further testing. The relations between nocturnal symptoms and CO,, formaldehyde, toluene, C8-aromates, terpenes, low boiling VOCs, and total VOCs were also significant in the logistic model (table 4) . Due to collinearity between formaldehyde and volatile Table 5 Correlation coefficientst between exposure organic compounds, however, these exposures could not be kept in the models simultaneously. The effects of house dust mites and carpeting on nocturnal chest tightness were, however, significant even when the effects of formaldehyde and VOCs were controlled. Finally, relations between clinical signs and indoor exposures were also investigated. No significant relations were found between bronchial hyperresponsiveness, variability in PEF, FEV,%, and presence of house dust mites, signs of dampness in the building, or microbial growth. For measured exposures, only compounds significantly related to nocturnal breathlessness in the logistic regression analysis were evaluated. Bronchial hyperresponsiveness was significantly related to the indoor concentration of limonene, the most prevalent terpene. Variability in PEF was related to the two other measured terpenes; a-pinene and 3-karen (table 5) . On average, 64% of the terpenes consisted of limonene, 15% of 3-karen, and 21% of ca-pinene. No activities known to emit terpenes, such as cleaning or peeling of citrus fruits, were observed during the measurements. No relations were found between bronchial hyperresponsiveness, variability in PEF, FEV,%, and the indoor concentration of formaldehyde, n-alkanes, aromatic compounds, or total VOCs. Furthermore, no significant relations were found between serum concentration of eosinophilic cationic protein, blood eosinophilic count, total serum immunoglobulin E concentration, and either carpeting, house dust mites, formaldehyde, or any of the VOCs significantly related to nocturnal breathlessness.
Discussion and conclusion
We have shown significant relations between asthmatic symptoms and dampness in the building, house dust mites, and indoor concentration of VOCs and formaldehyde. Also, significant relations between some clinical signs related to airway obstruction and the indoor concentration of terpenes were found.
The design was cross sectional and in such studies, selection effects may cause false negative results. This could be of particular significance for asthma, which is a severe condition. The failure to find a relation between pets and sensitisation is most probably due to health based selection that would cause sensitised subjects to avoid house pets. Moreover, the cross sectional design does not enable us to differentiate between exacerbation of symptoms in subjects with asthma, and induction of new asthma.
Many methodological problems of internal validity are inherent in an epidemiological study. In this particular study, selection bias due to low response rate is unlikely as the participation rate in the initial postal questionnaire was high (87%). Also, the participants and non-participants in the clinical study did not differ in age, atopy, smoking habits, or airway symptoms. Response bias due to awareness of exposure may cause a general overreporting of symptoms in exposed groups. Also, a time difference between clinical investigations and exposure measurements may induce a possible bias. In our study, however, the exposure measurements were performed in parallel with the medical investigations, and could not influence the reporting of symptoms.
Despite the limitations of the cross sectional design and the study size, we could show significant relations between VOCs and symptoms related to asthma. A large number of statistical tests were made, but most of the relations were significantly below the 1 % level, and similar results were obtained both in the crude analysis, and by logistic multiple regression analysis. Thus, we do not think that our conclusions are seriously biased by selection or response errors, or due to chance findings.
We found a relation between measured exposure and nocturnal symptoms, but not breathlessness during the daytime. One possible explanation could be that most people are not at home during the daytime, and if there is a cumulative effect of indoor pollutants at home it would be most likely to occur at the end of the night. Another explanation could be that the exposures are higher during the night than during the day, or that subjects are more susceptible to air pollutants during sleep. For practical reasons, our exposure measurements were performed during the day, without any subject in the bedroom. This enabled us to isolate the contribution of the building and its interior to the indoor concentrations of VOCs. During sleep however, human emissions are added to the background concentrations of VOCs, which could result in peak exposures higher than suggested by our measurements.
We found that the average indoor concentration of CO, was above the comfort value of 1000 ppm in many dwellings in Sweden. This inadequate outdoor air supply leads to increased concentrations of volatile organic compounds, as well as other indoor pollutants. Either the rate of outdoor air supply, or the indoor concentration of carbon dioxide, are used as criteria of ventilation by most ventilation standards,'1132 and a comfort value of 1000 ppm of CO2 has been adapted for work environments in Sweden.'2 There is, however, sparse information in the scientific literature on the medical significance of poor outdoor air supply. Our result, however, has shown that nocturnal symptoms related to asthma are more common if the outdoor air supply is inadequate.
We showed a relation between asthmatic symptoms and signs of dampness in the building or microbial growth, which is in agreement with earlier observations." 1-2 A relation between house dust mites and nocturnal asthmatic symptoms was also shown, even though most (95%) of the subjects had a negative prick test to Dermatophagoides pteronyssinus. Moreover, none of the four subjects with that positive prick test had house dust mites in their home, which suggests that they had been sensitised in earlier dwellings. A possible explanation for our findings could be that the presence of house dust mites in dwellings is related to other indoor pollutants that trigger asthmatic symptoms.
Respiratory effects of exposure to nitrogen dioxide (NO2) from gas cooking have been extensively studied in other countries.8 9 Our study was performed in a region where no gas cooking or gas heating was used. This made it possible to perform a study on respiratory effects of VOCs, which was not confounded by the emission of both VOCs and NO2 from gas combustion. Unfortunately, we did not measure indoor NO2 in our study. As possible sources of indoor NO2 in our study would have been traffic exhaust gases and indoor tobacco smoking, we expected the indoor concentrations of NO2 to be below the observed effect level of 30 ,Ug/m3 NO2.8 This assumption is supported by data from a recent study from mid-Sweden, where indoor concentrations of NO2 were between 4 and 18 ,ug/m3 in urban dwellings and 1-10,ug/m3 in rural dwellings."
We found significant relations between measured indoor concentrations of various VOCs in dwellings and symptoms related to asthma. To our knowledge, relations between asthmatic symptoms and measured VOCs have not been reported earlier in any epidemiological study. There are, however, some earlier studies that support the hypothesis that asthmatic symptoms may be related to indoor VOCs. In one population study, presence of newly painted surfaces indoors was related to asthmatic symptoms.34 Also, two experimental studies have shown that even moderate concentrations of VOCs may cause inflammation and obstructive reactions in the airways." 36 In one study, it was shown that a four hour exposure of humans to 25 mg/M3 of a mixture of VOCs induced an inflammatory response in the nose, as shown by a significant increase of granulocytes in nasal lavage." In the other study, the same mixture of VOCs, caused a decline of FEVy among asthmatic subjects after a 15 hour exposure to 25 mg/m3 of VOCs.36 To our knowledge, no exposure chamber studies of the effect on health related to asthma of VOCs below 25 mg/m3 are available. The average exposure in our study was well below 25 mg/m3n, but a maximum concentration of 9 mg/m3 was measured in the bedroom of one symptomatic subject. Moreover, the exposure time is much longer in dwellings than in exposure chamber studies, and the types of VOCs in our dwellings differed from the mixture of VOCs used in studies mentioned above. Thus we do not consider it unlikely that the concentrations of VOCs measured in our study may contribute to asthmatic symptoms in some sensitive subjects.
Our findings that indoor concentrations of formaldehyde are related to asthmatic symptoms agree with another study that suggests that dwellings with more than 30 ,g/m3 of formaldehyde had a higher proportion of children (< 15 years) with abnormal variability in PEF."7 Because of covariation between formaldehyde and VOCs, we were not able to separate the effect of these volatile compounds in our statistical analysis. Terpenes, however, were the only volatile compounds significantly related to both symptoms and clinical signs, including variability in PEF and bronchial hyperresponsiveness. We admit that it would have been better if we had measured peak flow four times a day, and a more frequent measurement of PEF may have increased the likelihood of detection of further health effects of indoor VOCs. Terpenes are usually considered to be harmless natural products, emitted from wood, paint, food, cleaners, and other consumer products. A maximum indoor concentration of IP0 mg/m3 of terpenes was measured in our study, about two thirds being limonene. No activities known to emit terpenes, such as cleaning, or peeling of citrus fruits, were found that could explain the high values. Obstructive airway reactions to terpenes have earlier been shown at higher concentrations in sawmills.38 Our investigation, however, suggests that some sensitive subjects may show bronchial obstructive reactions at low exposures to terpenes in the indoor environment.
To improve management of asthma, and to counteract the increase in asthma, the importance of the indoor environment should not be neglected. Our results suggest that indoor exposure to VOCs may affect the airways and cause asthmatic symptoms. Improved indoor environment can be achieved by various means-for example, selecting building material, building construction, and indoor activities on the principle that the emission of VOCs should be as low as reasonably achievable. There is also a need to increase the outdoor air supply in many dwellings in Sweden. Finally, wall to wall carpeting, which could act as a depot for various types of pollutants, and dampness in the building should also be avoided.
